dm+d
406442003
Refrigerated Storage
XolairNovartis Pharmaceuticals
Novartis Pharmaceuticals
Xolair
Solution for injection in pre-filled syringe (75mg and 150mg)
In the event of an inadvertent temperature excursion the following data may be used:
The product may be kept for a total of 48 hours at 25°C. If necessary, the product may be returned to the refrigerator for later use.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.
26 January 2022
London MI Service
Lactation Safety Information
Corticosteroids
Monoclonal antibody used for IgE-mediated allergic asthma
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties and likely to be degraded in infant’s GI tract, although long half-life increases risk of accumulation in breastfed infant
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
21 April 2017